Bristol-Myers Squibb (BMY) Q4 2022 Earnings Call Transcript

BMY earnings call for the period ending December 31, 2022.

Related Keywords

Puerto Rico , Japan , Netherlands , Canada , Massachusetts , United States , Andrew Baum , Chris Boerner , Chris Shibutani , Terence Flynn Morgan Stanley , Olivia Brayer Cantor Fitzgerald , Terence Flynn , Giovanni Caforio , Andrew Baum Citi , Geoff Meacham , Carter Gould Barclays , Steve Scala Cowen , Seamus Fernandez Guggenheim , David Elkins , Bristol Myers Squibb , Matt Phipps , Robert Plenge , Mohit Bansal , William Blair , Robyn Karnauskas , Tim Anderson , Evan Seigerman , Carter Gould , Samit Hirawat , Matt Phipps William Blair , Olivia Brayer , Steve Scala , America Merrill Lynch , Chris Schott Jpmorgan , Seamus Fernandez , Robyn Karnauskas Truist , Chris Shibutani Goldman Sachs , Chris Schott , Rupert Vessey , Colin Bristow , Morgan Stanley , Tim Anderson Wolfe Research Analyst , Head Of Global Drug Development , Goldman Sachs , Geoff Meacham Bank , Pfizer , Cantor Fitzgerald , Wolfe Research , Company Analyst , Barclays , Wells Fargo , Stim Power , Motley Fool Stock Advisor , Stock Advisor , Chief Executive , Medicare Coverage Gap , Turning Point , Turning Point Therapeutics , Medical Officer , Global Drug , Fargo Securities , Maybei Ll , Chief Commercialization , Guggenheim Partners , Chief Medical Officer , Wells Fargo Securities ,